Presentation is loading. Please wait.

Presentation is loading. Please wait.

Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American.

Similar presentations


Presentation on theme: "Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American."— Presentation transcript:

1 Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients  Jennifer Trofe-Clark, Daniel C. Brennan, Patricia West-Thielke, Michael C. Milone, Mary Ann Lim, Robin Neubauer, Vincenza Nigro, Roy D. Bloom  American Journal of Kidney Diseases  Volume 71, Issue 3, Pages (March 2018) DOI: /j.ajkd Copyright © 2017 The Authors Terms and Conditions

2 Figure 1 Study design. Abbreviations and definitions: IR-Tac, immediate-release tacrolimus; LCPT, extended-released tacrolimus (originally LifeCycle Pharma Tacrolimus); PK, pharmacokinetic. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2017 The Authors Terms and Conditions

3 Figure 2 Patient attrition flow diagram. Abbreviations and definitions: IR-Tac, immediate-release tacrolimus; LCPT, extended-release tacrolimus (originally LifeCycle Pharma Tacrolimus); LFT, liver function test; PK, pharmacokinetic. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2017 The Authors Terms and Conditions

4 Figure 3 Observed mean tacrolimus whole blood time-concentration curves for immediate-release tacrolimus (IR-Tac) and LCPT (extended-release tacrolimus; originally LifeCycle Pharma Tacrolimus). Abbreviations: AUC, area under the curve; SE, standard error; TDD, total daily dose. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2017 The Authors Terms and Conditions

5 Figure 4 Tacrolimus total daily dose (TDD) by CYP3A5 genotype.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2017 The Authors Terms and Conditions

6 Figure 5 Observed mean tacrolimus whole blood time-concentration curves by CYP3A5 expresser status for (A) immediate-release tacrolimus (IR-Tac) and (B) LCPT (extended-release tacrolimus; originally LifeCycle Pharma Tacrolimus). Abbreviations: AUC0-24, area under the concentration-time curve from time 0 to 24 hours; Cmax, maximum observed concentration, peak; SE, standard error; TDD, total daily dose. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2017 The Authors Terms and Conditions


Download ppt "Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American."

Similar presentations


Ads by Google